Personalized vitamin products market to reach $20.5 billion by 2030 at 13.5% cagr, driven by growing prevalence of chronic illnesses.
Read More
Personalized medicine biomarkers market to reach $58.8 billion by 2030 at 17.0% cagr, driven by growing prevalence of chronic diseases.
Read More
The global personalized medicine market to reach $733.27 billion by 2030 at 11.8% cagr, driven by growing obese population.
Read More
Personalized genomics market to reach $19.61 billion by 2030 at 15.7% cagr, driven by rising prevalence of chronic diseases.
Read More
Personalized gene therapy treatment market to reach $21.23 billion by 2030 at 20.4% cagr, driven by growing prevalence of genetic disorders.
Read More
Personalized dietary supplements market to reach $15.72 billion by 2030 at 10.9% cagr, driven by rising prevalence of lifestyle-related diseases.
Read More
Personalized cancer vaccines market to reach $350.3 billion by 2030 at 6.4% cagr, driven by increasing prevalence of cancer.
Read More
Peripheral vasodilator drugs market to reach $8.56 billion by 2030 at 5.2% cagr, driven by increasing prevalence of cardiovascular diseases.
Read MorePeripheral vasodilator drugs market to reach $8.56 billion by 2030 at 5.2% cagr, driven by increasing prevalence of cardiovascular diseases.
Read More
The Immunocytokines market size is expected to reach $5.44 billion in 2030 at a CAGR of 8.8%, driven by autoimmune disease prevalence.
Read More